Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Post by GasPro2017on Mar 05, 2020 5:57pm

223 Views

Post# 30772640

Does that gap at 0.41/0.42 have to close?

Yesterday I was waiting for it to close before I bought. Never got there....certainly wasn't going to buy this morning when it was at 0.99.

I'll wait till it hits 0.41, if that even happens. I am not saying it'll happen, so settle down, readers who are super bullish. I am just saying I'd feel nervouse buying now, knowing that gap might be filled.

If it does fill, I am sure it'll be swift, and head back up.

but who knows.

Bullboard Posts

Debt-free cannabis company set for next stage of growth